Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
“We expect that with the fast tracking of registration of Indian pharma products, we can significantly gain in the Omani pharma market which is estimated at USD 850 million,” Reddy said.